Peter J. van Santbrink

NLRP3 Inflammasome Inhibition by MCC950 Reduces Atherosclerotic Lesion Development in Apolipoprotein E–Deficient Mice—Brief Report

Thomas van der Heijden, Eva Kritikou, Wouter Venema et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2017 · 340 citations · Full text

Design and Synthesis of Novel Amphiphilic Dendritic Galactosides for Selective Targeting of Liposomes to the Hepatic Asialoglycoprotein Receptor

Leo A. J. M. Sliedregt, Patrick C.N. Rensen, Erik T. Rump et al. · Journal of Medicinal Chemistry · 1999 · 137 citations · Full text

Lipid Preparation, Drug Targeting, Biochemistry +15

Y-Box Binding Protein-1 Controls CC Chemokine Ligand-5 (CCL5) Expression in Smooth Muscle Cells and Contributes to Neointima Formation in Atherosclerosis-Prone Mice

Regina M. Krohn, Ute Raffetseder, Ilze Bot et al. · Circulation · 2007 · 125 citations · Full text

Quaking, an RNA-Binding Protein, Is a Critical Regulator of Vascular Smooth Muscle Cell Phenotype

Eric P. van der Veer, Ruben G. de Bruin, Adriaan O. Kraaijeveld et al. · Circulation Research · 2013 · 119 citations · Full text

Leukocyte-Specific CCL3 Deficiency Inhibits Atherosclerotic Lesion Development by Affecting Neutrophil Accumulation

Saskia C.A. de Jager, Ilze Bot, Adriaan O. Kraaijeveld et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2013 · 76 citations · Full text